trending Market Intelligence /marketintelligence/en/news-insights/trending/byGzUbSIn4fIczC8r9NYyA2 content esgSubNav
In This List

Kitov buys additional stake in TyrNovo

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Kitov buys additional stake in TyrNovo

Kitov Pharmaceuticals Holdings Ltd. acquired an additional 27% stake in TyrNovo Ltd. from unaffiliated minority shareholders for $7 million.

In exchange for the additional stake, Kitov will issue 13,169,689 new shares, or 658,484 American depositary shares, to the group of TyrNovo shareholders.

As a result of the transaction, Kitov now holds about 92% of TyrNovo's issued and outstanding shares. The company previously owned about 65% of TyrNovo.

TyrNovo is an Israel-based developer of novel small molecules in the oncology therapeutic field.